Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Venous Thrombosis

Free Subscription Articles published in Thromb Res Retrieve available abstracts of 272 articles: HTML format Text format

Single Articles

June 2018
1. CROLES FN, Mulder R, Mulder AB, Lukens MV, et al
   beta-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study.
   Thromb Res. 2018;168:47-52.
   PubMed     Text format     Abstract available
   
   
   
2. DELLUC A, Clemons M
   Poor outcomes after venous thromboembolism in cancer patients: It's time to change practice.
   Thromb Res. 2018 Jun 2. pii: S0049-3848(18)30377.
   PubMed     Text format    
   
   
   May 2018
3. SALIBA W, Warwar A, Kotler A, Cohen S, et al
   Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort study.
   Thromb Res. 2018;168:14-19.
   PubMed     Text format     Abstract available
   
   
   
4. COLEMAN CI, Peacock WF, Bunz TJ, Beyer-Westendorf J, et al
   Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study.
   Thromb Res. 2018;168:31-36.
   PubMed     Text format     Abstract available
   
   
   
5. MOESKER MJ, Damen NL, Volmeijer EE, Dreesens D, et al
   Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal.
   Thromb Res. 2018;168:5-13.
   PubMed     Text format     Abstract available
   
   
   
6. KLINE JA, Ellison AM, Kanis J, Pike JW, et al
   Evaluation of the pulmonary embolism rule out criteria (PERC rule) in children evaluated for suspected pulmonary embolism.
   Thromb Res. 2018;168:1-4.
   PubMed     Text format     Abstract available
   
   
   
7. FEEHAN M, Walsh M, Van Duker H, Godin J, et al
   Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model.
   Thromb Res. 2018 May 23. pii: S0049-3848(18)30366.
   PubMed     Text format     Abstract available
   
   
   
8. DRONKERS CEA, Lijfering WM, Teichert M, van der Meer FJM, et al
   Persistence to direct oral anticoagulants for acute venous thromboembolism.
   Thromb Res. 2018;167:135-141.
   PubMed     Text format     Abstract available
   
   
   
9. BURSTEIN B, Barbosa RS, Kalfon E, Joza J, et al
   Pulmonary embolism after electrophysiology procedures: Incidence from a single centre registry.
   Thromb Res. 2018;167:125-127.
   PubMed     Text format    
   
   
   
10. VANNI S, Becattini C, Nazerian P, Bova C, et al
    Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules.
    Thromb Res. 2018;167:37-43.
    PubMed     Text format     Abstract available
    
    
    
11. YOUNG K, Paz-Ares L, Thatcher N, Spigel DR, et al
    Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
    Thromb Res. 2018;167:50-56.
    PubMed     Text format     Abstract available
    
    
    
12. LAZO-LANGNER A, Al-Ani F, Weisz S, Rozanski C, et al
    Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study.
    Thromb Res. 2018;167:20-25.
    PubMed     Text format     Abstract available
    
    
    
13. TAKACH LAPNER S, Stevens SM, Woller SC, Snow G, et al
    Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism.
    Thromb Res. 2018;167:15-19.
    PubMed     Text format     Abstract available
    
    
    April 2018
14. HUANG D, Chan PH, She HL, Wong CK, et al
    Secular trends and etiologies of venous thromboembolism in Chinese from 2004 to 2016.
    Thromb Res. 2018;166:80-85.
    PubMed     Text format     Abstract available
    
    
    
15. SUN X, Li J, Shi J
    Validating the Chinese version of the PEmb-QoL questionnaire: A measure for quality of life assessment after pulmonary embolism.
    Thromb Res. 2018;166:86-91.
    PubMed     Text format     Abstract available
    
    
    
16. SIRBU IV, Nistor DO, Hutanu A, Banescu C, et al
    Can the electrocardiogram be used for predicting risk in patients with acute pulmonary embolism?
    Thromb Res. 2018;166:76.
    PubMed     Text format    
    
    
    
17. YAMASHITA Y, Morimoto T, Toyota T, Shiomi H, et al
    Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis.
    Thromb Res. 2018;166:37-42.
    PubMed     Text format     Abstract available
    
    
    
18. VAN ES N, Hisada Y, Di Nisio M, Cesarman G, et al
    Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
    Thromb Res. 2018;166:54-59.
    PubMed     Text format     Abstract available
    
    
    
19. ARROYO AB, de Los Reyes-Garcia AM, Teruel-Montoya R, Vicente V, et al
    microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
    Thromb Res. 2018;166:1-9.
    PubMed     Text format     Abstract available
    
    
    
20. PARRY BA, Chang AM, Schellong SM, House SL, et al
    International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs.
    Thromb Res. 2018;166:63-70.
    PubMed     Text format     Abstract available
    
    
    
21. BOVA C, Vanni S, Prandoni P, Morello F, et al
    A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism.
    Thromb Res. 2018;165:107-111.
    PubMed     Text format     Abstract available
    
    
    
22. ROBIN P, Carrier M
    Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
    Thromb Res. 2018;164 Suppl 1:S7-S11.
    PubMed     Text format     Abstract available
    
    
    
23. LIEBMAN HA
    Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk.
    Thromb Res. 2018;164 Suppl 1:S19-S22.
    PubMed     Text format     Abstract available
    
    
    
24. PIRAN S, Schulman S
    Management of recurrent venous thromboembolism in patients with cancer: A review.
    Thromb Res. 2018;164 Suppl 1:S172-S177.
    PubMed     Text format     Abstract available
    
    
    
25. VERSO M, Franco L, Giustozzi M, Becattini C, et al
    Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Thromb Res. 2018;164 Suppl 1:S168-S171.
    PubMed     Text format     Abstract available
    
    
    
26. KIMPTON M, Wells PS, Carrier M
    Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial.
    Thromb Res. 2018;164 Suppl 1:S124-S129.
    PubMed     Text format     Abstract available
    
    
    
27. GRAN OV, Braekkan SK, Hansen JB
    Prothrombotic genotypes and risk of venous thromboembolism in cancer.
    Thromb Res. 2018;164 Suppl 1:S12-S18.
    PubMed     Text format     Abstract available
    
    
    
28. LYMAN GH, Culakova E, Poniewierski MS, Kuderer NM, et al
    Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.
    Thromb Res. 2018;164 Suppl 1:S112-S118.
    PubMed     Text format     Abstract available
    
    
    March 2018
29. JOHANSSON M, Lind M, Jansson JH, Fharm E, et al
    Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.
    Thromb Res. 2018;165:86-94.
    PubMed     Text format     Abstract available
    
    
    
30. OEDINGEN C, Scholz S, Razum O
    Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose.
    Thromb Res. 2018;165:68-78.
    PubMed     Text format     Abstract available
    
    
    
31. THURN L, Wikman A, Lindqvist PG
    Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism.
    Thromb Res. 2018;165:54-60.
    PubMed     Text format     Abstract available
    
    
    
32. VOILS SA, Shahin MH, Garrett TJ, Frye RF, et al
    Metabolomic association between venous thromboembolism in critically ill trauma patients and kynurenine pathway of tryptophan metabolism.
    Thromb Res. 2018;165:6-13.
    PubMed     Text format     Abstract available
    
    
    
33. LEE YH, Cha SI, Shin KM, Lim JK, et al
    Clinical relevance of syncope in patients with pulmonary embolism.
    Thromb Res. 2018;164:85-89.
    PubMed     Text format     Abstract available
    
    
    
34. PESAVENTO R, Prandoni P
    Prevention and treatment of the chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Mar 2. pii: S0049-3848(18)30264.
    PubMed     Text format     Abstract available
    
    
    
35. PRASCA S, Carmona R, Ji L, Ko RH, et al
    Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
    Thromb Res. 2018;165:44-50.
    PubMed     Text format     Abstract available
    
    
    
36. GAL GL, Righini M
    Preface to Diagnosis of venous thromboembolism.
    Thromb Res. 2018;163:200.
    PubMed     Text format    
    
    
    February 2018
37. QUEZADA CA, Bikdeli B, Barrios D, Morillo R, et al
    Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism.
    Thromb Res. 2018;164:40-44.
    PubMed     Text format     Abstract available
    
    
    
38. BRANCHFORD BR, Betensky M, Goldenberg NA
    Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children.
    Thromb Res. 2018 Feb 17. pii: S0049-3848(18)30072.
    PubMed     Text format     Abstract available
    
    
    
39. KAHN SR, Pengo V
    Special issue: Late consequences of venous thromboembolism.
    Thromb Res. 2018 Feb 13. pii: S0049-3848(18)30067.
    PubMed     Text format    
    
    
    
40. JAFFRAY J, Rajpurkar M, Sharathkumar A, Patel K, et al
    Transition of care for patients with venous thromboembolism: Rationale, design and implementation of a quality intervention project conducted at American Thrombosis and Hemostasis Network (ATHN) affiliated sites.
    Thromb Res. 2018;163:146-152.
    PubMed     Text format     Abstract available
    
    
    January 2018
41. SAMUELSON BANNOW BT, Konkle BA
    Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review.
    Thromb Res. 2018;163:138-145.
    PubMed     Text format     Abstract available
    
    
    
42. COLEMAN CI, Turpie AGG, Bunz TJ, Baker WL, et al
    Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state.
    Thromb Res. 2018;163:132-137.
    PubMed     Text format     Abstract available
    
    
    
43. RODGER M, Langlois N, Middeldorp S, Kahn S, et al
    Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.
    Thromb Res. 2018;163:128-131.
    PubMed     Text format     Abstract available
    
    
    
44. CASAZZA F, Pacchetti I, Rulli E, Roncon L, et al
    Prognostic significance of electrocardiogram at presentation in patients with pulmonary embolism of different severity.
    Thromb Res. 2018;163:123-127.
    PubMed     Text format     Abstract available
    
    
    
45. BEYER-WESTENDORF J
    What have we learned from real-world NOAC studies in venous thromboembolism treatment?
    Thromb Res. 2018;163:83-91.
    PubMed     Text format     Abstract available
    
    
    
46. VAN ES N, Louzada M, Carrier M, Tagalakis V, et al
    Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study.
    Thromb Res. 2018;163:41-46.
    PubMed     Text format     Abstract available
    
    
    
47. FERNANDES T, Auger W, Fedullo P
    Epidemiology and risk factors for chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Jan 8. pii: S0049-3848(18)30012.
    PubMed     Text format    
    
    
    
48. SIUDUT J, Natorska J, Zabczyk M, Zajac D, et al
    Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation.
    Thromb Res. 2018;163:12-18.
    PubMed     Text format     Abstract available
    
    
    
49. KARATHANOS C, Spanos K, Giannoukas A
    Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode.
    Thromb Res. 2018;162:77-78.
    PubMed     Text format    
    
    
    December 2017
50. VANASSCHE T, Verhamme P, Wells PS, Segers A, et al
    Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
    Thromb Res. 2017;162:7-14.
    PubMed     Text format     Abstract available
    
    
    
51. WAN T, Rodger M, Zeng W, Robin P, et al
    Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Thromb Res. 2017 Dec 7. pii: S0049-3848(17)30582.
    PubMed     Text format     Abstract available
    
    
    
52. JIMENEZ D, Nieto R, Corres J, Fernandez-Golfin C, et al
    Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.
    Thromb Res. 2017;162:1-6.
    PubMed     Text format     Abstract available
    
    
    November 2017
53. JIMENEZ D, Yusen RD
    Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base.
    Thromb Res. 2017 Nov 26. pii: S0049-3848(17)30584.
    PubMed     Text format    
    
    
    
54. BACH AG, Taute BM, Surov A
    Time to threshold as a new indicator of circulatory state and prognosis in patients with pulmonary embolism.
    Thromb Res. 2017;161:26-32.
    PubMed     Text format     Abstract available
    
    
    
55. KLIL-DRORI AJ, Coulombe J, Suissa S, Hirsch A, et al
    Temporal trends in outpatient management of incident pulmonary embolism and associated mortality.
    Thromb Res. 2017 Nov 6. pii: S0049-3848(17)30542.
    PubMed     Text format     Abstract available
    
    
    October 2017
56. POPOOLA VO, Tavakoli F, Lau BD, Lankiewicz M, et al
    Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism prevention.
    Thromb Res. 2017;160:109-113.
    PubMed     Text format     Abstract available
    
    
    
57. FALLER N, Stalder O, Limacher A, Bassetti S, et al
    Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents.
    Thromb Res. 2017;160:9-13.
    PubMed     Text format     Abstract available
    
    
    
58. RATTAZZI M, Villalta S, De Lucchi L, Sponchiado A, et al
    Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence.
    Thromb Res. 2017;160:32-37.
    PubMed     Text format     Abstract available
    
    
    
59. ZIA A, Russell J, Sarode R, Veeram SR, et al
    Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2017;160:1-8.
    PubMed     Text format     Abstract available
    
    
    September 2017
60. ROBIN P, Le Roux PY, Tromeur C, Planquette B, et al
    Risk factors of occult malignancy in patients with unprovoked venous thromboembolism.
    Thromb Res. 2017;159:48-51.
    PubMed     Text format     Abstract available
    
    
    
61. KRISTOFFERSEN AH, Ajzner E, Bauca JM, Carraro P, et al
    Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments.
    Thromb Res. 2017;159:19-23.
    PubMed     Text format    
    
    
    
62. KHARAT A, Hachulla AL, Noble S, Lador F, et al
    Modern diagnosis of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2017 Sep 9. pii: S0049-3848(17)30486.
    PubMed     Text format     Abstract available
    
    
    
63. BARRIOS D, Morillo R, Yusen RD, Jimenez D, et al
    Pulmonary embolism severity assessment and prognostication.
    Thromb Res. 2017 Sep 8. pii: S0049-3848(17)30485.
    PubMed     Text format     Abstract available
    
    
    
64. KNIGHT-PERRY J, Branchford BR, Thornhill D, Martiniano SL, et al
    Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors.
    Thromb Res. 2017;158:161-166.
    PubMed     Text format     Abstract available
    
    
    
65. GADE IL, Braekkan S, Naess IA, Hansen JB, et al
    Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort.
    Thromb Res. 2017;158:157-160.
    PubMed     Text format     Abstract available
    
    
    
66. CHAN WS
    Diagnosis of venous thromboembolism in pregnancy.
    Thromb Res. 2017 Sep 5. pii: S0049-3848(17)30482.
    PubMed     Text format     Abstract available
    
    
    August 2017
67. MEZEI ZA, Katona E, Kallai J, Bereczky Z, et al
    Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
    Thromb Res. 2017;158:93-97.
    PubMed     Text format     Abstract available
    
    
    
68. KONIGSBRUGGE O, Lorenz M, Auinger M, Schmaldienst S, et al
    Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIV
    Thromb Res. 2017;158:59-64.
    PubMed     Text format     Abstract available
    
    
    
69. EL-REFAI SM, Black EP, Adams VR, Talbert JC, et al
    Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study.
    Thromb Res. 2017;158:49-58.
    PubMed     Text format     Abstract available
    
    
    July 2017
70. BAUERSACHS R, Agnelli G, Gitt AK, Monreal M, et al
    The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.
    Thromb Res. 2017;157:181-188.
    PubMed     Text format     Abstract available
    
    
    
71. DZIKOWSKA-DIDUCH O, Domienik-Karlowicz J, Gorska E, Demkow U, et al
    E-selectin and sICAM-1, biomarkers of endothelial function, predict recurrence of venous thromboembolism.
    Thromb Res. 2017;157:173-180.
    PubMed     Text format     Abstract available
    
    
    
72. GHANIMA W, Wik HS, Tavoly M, Enden T, et al
    Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism.
    Thromb Res. 2017 Jul 23. pii: S0049-3848(17)30434.
    PubMed     Text format     Abstract available
    
    
    
73. ZHOU M, Zhang L, Ding Y, Wang Y, et al
    Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.
    Thromb Res. 2017;157:147-153.
    PubMed     Text format     Abstract available
    
    
    
74. PRANDONI P, Lensing AWA, Prins MH, Noventa F, et al
    Does the presence of clinical symptoms of pulmonary embolism affect the outcome of patients with deep vein thrombosis?
    Thromb Res. 2017;157:134-135.
    PubMed     Text format    
    
    
    June 2017
75. LE ROUX PY, Robin P, Salaun PY
    New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism.
    Thromb Res. 2017 Jun 27. pii: S0049-3848(17)30394.
    PubMed     Text format     Abstract available
    
    
    
76. ARENDT JFH, Farkas DK, Pedersen L, Sorensen HT, et al
    Elevated plasma vitamin B12 levels and risk of venous thromboembolism among cancer patients: A population-based cohort study.
    Thromb Res. 2017;156:177-183.
    PubMed     Text format     Abstract available
    
    
    
77. WALEN S, Katerberg B, Boomsma MF, van den Berg JWK, et al
    Safety, feasibility and patient reported outcome measures of outpatient treatment of pulmonary embolism.
    Thromb Res. 2017;156:172-176.
    PubMed     Text format     Abstract available
    
    
    
78. WAN T, Skeith L, Karovitch A, Rodger M, et al
    Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies.
    Thromb Res. 2017;157:23-28.
    PubMed     Text format     Abstract available
    
    
    
79. HELLMAN T, Kiviniemi T, Nuotio I, Vasankari T, et al
    Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
    Thromb Res. 2017;156:163-167.
    PubMed     Text format     Abstract available
    
    
    
80. KRUGER S, Haas M, Burkl C, Goehring P, et al
    Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Thromb Res. 2017;157:9-15.
    PubMed     Text format     Abstract available
    
    
    
81. SISTA AK, Klok FA
    Late outcomes of pulmonary embolism: The post-PE syndrome.
    Thromb Res. 2017 Jun 16. pii: S0049-3848(17)30381.
    PubMed     Text format     Abstract available
    
    
    
82. MA Y, Wang Y, Liu D, Ning Z, et al
    A safe strategy to rule out pulmonary embolism: The combination of the Wells score and D-dimer test: One prospective study.
    Thromb Res. 2017;156:160-162.
    PubMed     Text format    
    
    
    
83. SHARMA S, Lang IM
    Current understanding of the pathophysiology of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2017 Jun 12. pii: S0049-3848(17)30375.
    PubMed     Text format     Abstract available
    
    
    
84. DONADINI MP, Dentali F, Castellaneta M, Gnerre P, et al
    Pulmonary embolism prognostic factors and length of hospital stay: A cohort study.
    Thromb Res. 2017;156:155-159.
    PubMed     Text format     Abstract available
    
    
    
85. MANSOUR S, Alotaibi G, Wu C, McMurtry MS, et al
    Trends in admission rates and in-hospital stay for venous thromboembolism.
    Thromb Res. 2017;156:149-154.
    PubMed     Text format     Abstract available
    
    
    
86. AL MEGREN M, De Wit C, Al Qahtani M, Le Gal G, et al
    Management of venous thromboembolism in patients with glioma.
    Thromb Res. 2017;156:105-108.
    PubMed     Text format     Abstract available
    
    
    
87. KLINE JA
    Diagnosis and Exclusion of Pulmonary Embolism.
    Thromb Res. 2017 Jun 7. pii: S0049-3848(17)30358.
    PubMed     Text format     Abstract available
    
    
    
88. KONSTANTINIDES SV, Barco S
    Prevention of early complications and late consequences after acute pulmonary embolism: Focus on reperfusion techniques.
    Thromb Res. 2017 Jun 1. pii: S0049-3848(17)30352.
    PubMed     Text format     Abstract available
    
    
    
89. HUSSEINZADEH H, Carrier M
    Occult cancer detection in patients with hemostatic disorder and venous thromboembolism.
    Thromb Res. 2017 Jun 1. pii: S0049-3848(17)30354.
    PubMed     Text format     Abstract available
    
    
    May 2017
90. LIEDL G, Nazerian P, Pepe G, Caviglioli C, et al
    Different time course of plasma lactate, troponin I and Nt-proBNP concentrations in patients with acute pulmonary embolism.
    Thromb Res. 2017;156:26-28.
    PubMed     Text format    
    
    
    
91. BARCO S, Konstantinides S, Huisman MV, Klok FA, et al
    Diagnosis of recurrent venous thromboembolism.
    Thromb Res. 2017 May 26. pii: S0049-3848(17)30344.
    PubMed     Text format     Abstract available
    
    
    
92. LUONG NV, Kroll MH, Vu K
    Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors.
    Thromb Res. 2017;156:14-19.
    PubMed     Text format     Abstract available
    
    
    
93. TRITSCHLER T, Aujesky D
    Venous thromboembolism in the elderly: A narrative review.
    Thromb Res. 2017;155:140-147.
    PubMed     Text format     Abstract available
    
    
    
94. REZANIA S, Puskarich MA, Petrusca DN, Neto-Neves EM, et al
    Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism.
    Thromb Res. 2017;155:106-115.
    PubMed     Text format     Abstract available
    
    
    
95. ROY PM, Moumneh T, Penaloza A, Sanchez O, et al
    Outpatient management of pulmonary embolism.
    Thromb Res. 2017;155:92-100.
    PubMed     Text format     Abstract available
    
    
    
96. WASSEF A, Lim W, Wu C
    Indications, complications and outcomes of inferior vena cava filters: A retrospective study.
    Thromb Res. 2017;153:123-128.
    PubMed     Text format     Abstract available
    
    
    April 2017
97. ROBIN P, Le Roux PY, Le Moigne E, Planquette B, et al
    Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
    Thromb Res. 2017;155:6-9.
    PubMed     Text format     Abstract available
    
    
    
98. DITTMAR M, Smith N, Warren B, Clark B, et al
    Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by addition of radiographic and pharmacologic elements.
    Thromb Res. 2017;154:93-95.
    PubMed     Text format    
    
    
    
99. LANGE N, Stalder O, Aujesky D
    Is clinical pre-test probability assessment for venous thromboembolism underused?
    Thromb Res. 2017;155:10-11.
    PubMed     Text format    
    
    
    
100. KEVANE B, Ainle FN
     Contraception and menstrual bleeding during venous thromboembolism treatment: Does current practice reflect expert option?
     Thromb Res. 2017 Apr 12. pii: S0049-3848(17)30281.
     PubMed     Text format    
     
     
     
101. CHU JN, Maselli J, Auerbach AD, Fang MC, et al
     The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
     Thromb Res. 2017;155:65-71.
     PubMed     Text format     Abstract available
     
     
     
102. SQUIZZATO A, Pomero F, Allione A, Priotto R, et al
     Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis.
     Thromb Res. 2017;154:64-72.
     PubMed     Text format     Abstract available
     
     
     March 2017
103. GON Y, Sakaguchi M, Takasugi J, Mochizuki H, et al
     Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism.
     Thromb Res. 2017;154:16-18.
     PubMed     Text format     Abstract available
     
     
     
104. KLOK FA, Schreiber K, Stach K, Ageno W, et al
     Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.
     Thromb Res. 2017;153:101-107.
     PubMed     Text format     Abstract available
     
     
     
105. BRUNSON A, Ho G, White R, Wun T, et al
     Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study.
     Thromb Res. 2017;153:57-64.
     PubMed     Text format     Abstract available
     
     
     
106. BEYAN C, Beyan E
     Mean platelet volume may not be an alternative test instead of platelet aggregation in patients with venous thromboembolism.
     Thromb Res. 2017;153:50.
     PubMed     Text format    
     
     
     
107. MA K, Kahn SR, Hirsch AM, Akaberi A, et al
     N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.
     Thromb Res. 2017;153:47-49.
     PubMed     Text format    
     
     
     
108. RUHLE F, Stoll M
     Genetic factors in pediatric venous thromboembolism.
     Thromb Res. 2017;151 Suppl 1:S97-S99.
     PubMed     Text format     Abstract available
     
     
     
109. BARCO S, Konstantinides SV
     Risk-adapted management of pulmonary embolism.
     Thromb Res. 2017;151 Suppl 1:S92-S96.
     PubMed     Text format     Abstract available
     
     
     
110. TROMEUR C, van der Pol LM, Klok FA, Couturaud F, et al
     Pitfalls in the diagnostic management of pulmonary embolism in pregnancy.
     Thromb Res. 2017;151 Suppl 1:S86-S91.
     PubMed     Text format     Abstract available
     
     
     
111. BLANCO-MOLINA A, Trujillo-Santos J, Pesavento R, Rosa V, et al
     Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
     Thromb Res. 2017;151 Suppl 1:S6-S10.
     PubMed     Text format     Abstract available
     
     
     
112. MARTIN-MARTOS F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, et al
     Gender differences in patients with venous thromboembolism and five common sites of cancer.
     Thromb Res. 2017;151 Suppl 1:S16-S20.
     PubMed     Text format     Abstract available
     
     
     
113. TZORAN I, Papadakis E, Brenner B, Valle R, et al
     Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
     Thromb Res. 2017;151 Suppl 1:S11-S15.
     PubMed     Text format     Abstract available
     
     
     
114. MOUSTAFA F, Fernandez S, Fernandez-Capitan C, Nieto JA, et al
     Uterine bleeding during anticoagulation in women with venous thromboembolism.
     Thromb Res. 2017;151 Suppl 1:S1-S5.
     PubMed     Text format     Abstract available
     
     
     February 2017
115. VAN ES N, Wells PS, Carrier M
     Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
     Thromb Res. 2017;152:52-60.
     PubMed     Text format     Abstract available
     
     
     
116. WILTS IT, Le Gal G, Den Exter PL, Van Es J, et al
     Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.
     Thromb Res. 2017;152:49-51.
     PubMed     Text format     Abstract available
     
     
     
117. THEBERGE I, Bowdridge J, Forgie MA, Carrier M, et al
     Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
     Thromb Res. 2017;152:4-6.
     PubMed     Text format    
     
     
     
118. NOJIMA J, Motoki Y, Hara K, Sakata T, et al
     Detection of antibodies against domain 1 of beta2-glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus.
     Thromb Res. 2017;153:83-84.
     PubMed     Text format    
     
     
     January 2017
119. KHORANA AA, Francis CW, Kuderer NM, Carrier M, et al
     Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
     Thromb Res. 2017 Jan 26. pii: S0049-3848(17)30020.
     PubMed     Text format     Abstract available
     
     
     
120. PUURUNEN MK, Hwang SJ, O'Donnell CJ, Tofler G, et al
     Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study.
     Thromb Res. 2017;151:57-62.
     PubMed     Text format     Abstract available
     
     
     
121. COWAN LT, Lutsey PL, Pankow JS, Cushman M, et al
     Hospitalization with infection and incident venous thromboembolism: The ARIC study.
     Thromb Res. 2017;151:74-78.
     PubMed     Text format     Abstract available
     
     
     
122. COYLE K, Carrier M, Lazo-Langner A, Shivakumar S, et al
     Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
     Thromb Res. 2017;151:67-71.
     PubMed     Text format     Abstract available
     
     
     
123. KUO TH, Li HY, Lin SH
     Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: A nationwide retrospective cohort study.
     Thromb Res. 2017;151:29-35.
     PubMed     Text format     Abstract available
     
     
     
124. ENDE-VERHAAR YM, Huisman MV, Klok FA
     To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
     Thromb Res. 2017;151:1-7.
     PubMed     Text format     Abstract available
     
     
     December 2016
125. ZOLLER B, Li X, Ohlsson H, Sundquist J, et al
     Seasonal variation of pulmonary embolism and age dependence.
     Thromb Res. 2016;150:76-77.
     PubMed     Text format    
     
     
     
126. ROSS JA, Miller MM, Rojas Hernandez CM
     Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
     Thromb Res. 2016;150:86-89.
     PubMed     Text format     Abstract available
     
     
     
127. VAN ES N, Franke VF, Middeldorp S, Wilmink JW, et al
     The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
     Thromb Res. 2016;150:30-32.
     PubMed     Text format     Abstract available
     
     
     
128. SWIER N, Versteeg HH
     Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
     Thromb Res. 2016;150:8-18.
     PubMed     Text format     Abstract available
     
     
     
129. OZCAN CETIN EH, Cetin MS, Canpolat U, Akdi A, et al
     Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.
     Thromb Res. 2016;150:33-40.
     PubMed     Text format     Abstract available
     
     
     
130. PIOVELLA F, Iosub DI
     Extended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrent venous thromboembolism.
     Thromb Res. 2016 Dec 7. pii: S0049-3848(16)30645.
     PubMed     Text format     Abstract available
     
     
     
131. GARCIA-HORTON A, Kovacs MJ, Abdulrehman J, Taylor JE, et al
     Impact of thrombophilia screening on venous thromboembolism management practices.
     Thromb Res. 2016;149:76-80.
     PubMed     Text format     Abstract available
     
     
     November 2016
132. OLIE V, Bonaldi C
     Pulmonary embolism: Does the seasonal effect depend on age? A 12-year nationwide analysis of hospitalization and mortality.
     Thromb Res. 2016 Nov 30. pii: S0049-3848(16)30640.
     PubMed     Text format     Abstract available
     
     
     
133. LIN CL, Lin CL, Tzeng SL, Chung WS, et al
     Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study.
     Thromb Res. 2016;149:70-75.
     PubMed     Text format     Abstract available
     
     
     
134. BURWEN DR, Wu C, Cirillo D, Rossouw JE, et al
     Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims.
     Thromb Res. 2016;150:78-85.
     PubMed     Text format     Abstract available
     
     
     October 2016
135. PLANQUETTE B, Ferre A, Peron J, Vial-Dupuy A, et al
     Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
     Thromb Res. 2016;148:70-75.
     PubMed     Text format     Abstract available
     
     
     
136. ALEXANDER M, Burbury K
     A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - Results, practical issues and proposed strategies for future risk prediction models.
     Thromb Res. 2016;148:63-69.
     PubMed     Text format     Abstract available
     
     
     
137. BEYER-WESTENDORF J
     Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboem
     Thromb Res. 2016 Oct 26. pii: S0049-3848(16)30601.
     PubMed     Text format    
     
     
     
138. ZOLLER B, Ohlsson H, Sundquist J, Sundquist K, et al
     A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden.
     Thromb Res. 2016 Oct 20. pii: S0049-3848(16)30587.
     PubMed     Text format     Abstract available
     
     
     
139. KANG J, Lee JS, Lee JH, Lee KM, et al
     Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura.
     Thromb Res. 2016;148:23-24.
     PubMed     Text format    
     
     
     
140. MELANCON T, Bivona C, Klenke S, Rockey M, et al
     Comparison of postoperative venous thromboembolism incidence in gastrointestinal and gynecologic solid tumors.
     Thromb Res. 2016;147:104-107.
     PubMed     Text format     Abstract available
     
     
     
141. RABINOVICH E, Bartholomew JR, Wilks ML, Tripp BL, et al
     Centralizing care of cancer-associated thromboembolism: The Cleveland Clinic experience.
     Thromb Res. 2016;147:102-103.
     PubMed     Text format    
     
     
     
142. PIRAN S, Schulman S
     Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
     Thromb Res. 2016;147:97-101.
     PubMed     Text format     Abstract available
     
     
     September 2016
143. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
     Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study.
     Thromb Res. 2016;147:88-93.
     PubMed     Text format     Abstract available
     
     
     
144. VINSON DR, Ballard DW, Mark DG, Huang J, et al
     Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
     Thromb Res. 2016;148:1-8.
     PubMed     Text format     Abstract available
     
     
     
145. DEMELO-RODRIGUEZ P, Postigo-Esteban A, Garcia-Fernandez-Bravo I, Agud M, et al
     Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
     Thromb Res. 2016;147:58-60.
     PubMed     Text format     Abstract available
     
     
     
146. VOILS SA, Lemon SJ, Jordan J, Riley P, et al
     Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
     Thromb Res. 2016;147:13-15.
     PubMed     Text format     Abstract available
     
     
     
147. BLEKER SM, Beenen LF, Di Nisio M, van Es N, et al
     Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots.
     Thromb Res. 2016;147:46-51.
     PubMed     Text format     Abstract available
     
     
     
148. ARACHCHILLAGE D, Reynolds R, Devey T, Maclean R, et al
     Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
     Thromb Res. 2016;147:32-35.
     PubMed     Text format    
     
     
     
149. KRAUSE M, Henningsen A, Torge A, Juhl D, et al
     Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
     Thromb Res. 2016 Sep 13. pii: S0049-3848(16)30542.
     PubMed     Text format    
     
     
     August 2016
150. PETCH S, Norris L, O'Toole S, Gleeson N, et al
     Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice.
     Thromb Res. 2016;145:126-128.
     PubMed     Text format    
     
     
     July 2016
151. GROSSE SD
     Cost-of-illness models for venous thromboembolism: One size does not fit all.
     Thromb Res. 2016;145:65-66.
     PubMed     Text format    
     
     
     
152. HOFMANN E, Limacher A, Mean M, Kucher N, et al
     Echocardiography does not predict mortality in hemodynamically stable elderly patients with acute pulmonary embolism.
     Thromb Res. 2016;145:67-71.
     PubMed     Text format     Abstract available
     
     
     
153. KHORANA AA, Yannicelli D, McCrae KR, Milentijevic D, et al
     Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
     Thromb Res. 2016;145:51-53.
     PubMed     Text format     Abstract available
     
     
     
154. PUURUNEN MK, Enserro D, Xanthakis V, Larson MG, et al
     Biomarkers for the prediction of venous thromboembolism in the community.
     Thromb Res. 2016;145:34-39.
     PubMed     Text format     Abstract available
     
     
     June 2016
155. PUURUNEN MK, Gona PN, Larson MG, Murabito JM, et al
     Epidemiology of venous thromboembolism in the Framingham Heart Study.
     Thromb Res. 2016;145:27-33.
     PubMed     Text format     Abstract available
     
     
     
156. MAHAN CE, Barco S, Spyropoulos AC
     Cost-of-illness model for venous thromboembolism.
     Thromb Res. 2016 Jun 23. pii: S0049-3848(16)30460.
     PubMed     Text format    
     
     
     
157. KUBOTA Y, McAdams-DeMarco M, Folsom AR
     Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study.
     Thromb Res. 2016;144:144-148.
     PubMed     Text format     Abstract available
     
     
     
158. ROUZAUD D, Alexandra JF, Chauchard M, Delon M, et al
     Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
     Thromb Res. 2016;144:116-118.
     PubMed     Text format    
     
     
     
159. CUSHMAN M, O'Meara ES, Heckbert SR, Zakai NA, et al
     Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology.
     Thromb Res. 2016;144:127-132.
     PubMed     Text format     Abstract available
     
     
     
160. BLEKER SM, Buchmuller A, Chauleur C, Ainle FN, et al
     Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
     Thromb Res. 2016;144:62-68.
     PubMed     Text format     Abstract available
     
     
     
161. AMBRUS DB, Reisman JI, Rose AJ
     The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism.
     Thromb Res. 2016;144:21-26.
     PubMed     Text format     Abstract available
     
     
     May 2016
162. BAUERSACHS R
     Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism.
     Thromb Res. 2016;144:12-20.
     PubMed     Text format     Abstract available
     
     
     
163. GARCIA-OLIVARES P, Guerrero JE, Keough E, Galdos P, et al
     Clinical factors associated with inappropriate prophylaxis of venous thromboembolic disease in critically ill patients. A single day cross-sectional study.
     Thromb Res. 2016;143:111-117.
     PubMed     Text format     Abstract available
     
     
     
164. CARMONA-BAYONAS A, Font C, Jimenez-Fonseca P, Fenoy F, et al
     On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism.
     Thromb Res. 2016;143:76-85.
     PubMed     Text format     Abstract available
     
     
     
165. BARNES GD, Izzo B, Conte ML, Chopra V, et al
     Use of decision aids for shared decision making in venous thromboembolism: A systematic review.
     Thromb Res. 2016;143:71-75.
     PubMed     Text format     Abstract available
     
     
     
166. SANFILIPPO KM, Wang TF, Gage BF, Luo S, et al
     Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
     Thromb Res. 2016;143:86-90.
     PubMed     Text format     Abstract available
     
     
     
167. NICKEL KF, Labberton L, Long AT, Langer F, et al
     The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
     Thromb Res. 2016;141 Suppl 2:S4-7.
     PubMed     Text format     Abstract available
     
     
     
168. GAUTHIER K, Le Gal G, Shivakumar S, Anderson D, et al
     Inter-observer reliability of the HERDOO2 clinical decision rule.
     Thromb Res. 2016;141:136-8.
     PubMed     Text format    
     
     
     April 2016
169. RODGER MA, Phillips P, Kahn SR, Bates S, et al
     Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.
     Thromb Res. 2016;142:17-20.
     PubMed     Text format    
     
     
     
170. KRISTOFFERSEN AH, Ajzner E, Rogic D, Sozmen EY, et al
     Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries.
     Thromb Res. 2016;142:1-7.
     PubMed     Text format     Abstract available
     
     
     
171. MENAPACE LA, McCrae KR, Khorana AA
     Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
     Thromb Res. 2016;140 Suppl 1:S93-8.
     PubMed     Text format     Abstract available
     
     
     
172. GHESHMY A, Carrier M
     Venous thromboembolism and occult cancer: impact on clinical practice.
     Thromb Res. 2016;140 Suppl 1:S8-S11.
     PubMed     Text format     Abstract available
     
     
     
173. LIEBMAN HA, O'Connell C
     Incidental venous thromboembolic events in cancer patients: what we know in 2016.
     Thromb Res. 2016;140 Suppl 1:S18-20.
     PubMed     Text format     Abstract available
     
     
     
174. BRUNSON A, Ho G, White R, Wun T, et al
     Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes.
     Thromb Res. 2016;140 Suppl 1:S132-41.
     PubMed     Text format     Abstract available
     
     
     
175. ROMUALDI E, Ageno W
     Management of recurrent venous thromboembolism in cancer patients.
     Thromb Res. 2016;140 Suppl 1:S128-31.
     PubMed     Text format     Abstract available
     
     
     
176. RIEDL J, Kaider A, Marosi C, Prager G, et al
     PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis.
     Thromb Res. 2016;140 Suppl 1:S199-200.
     PubMed     Text format     Abstract available
     
     
     
177. WELLS PS, Theberge IA, Bowdridge JC, Forgie MA, et al
     PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease.
     Thromb Res. 2016;140 Suppl 1:S191-2.
     PubMed     Text format     Abstract available
     
     
     
178. MANCUSO A, Vedovati MC, Pierpaoli L, Paliani U, et al
     PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort.
     Thromb Res. 2016;140 Suppl 1:S191.
     PubMed     Text format     Abstract available
     
     
     
179. WILTS IT, Le Gal G, den Exter PL, van Es J, et al
     PO-29 - Age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy.
     Thromb Res. 2016;140 Suppl 1:S187.
     PubMed     Text format     Abstract available
     
     
     
180. VAN ES N, van der Hulle T, van Es J, den Exter PL, et al
     PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis.
     Thromb Res. 2016;140 Suppl 1:S179.
     PubMed     Text format     Abstract available
     
     
     
181. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
     PO-06 - Cancer and the risk of venous thromboembolism in stroke patients.
     Thromb Res. 2016;140 Suppl 1:S178.
     PubMed     Text format     Abstract available
     
     
     
182. ADRIAN SG, de Castro EM, Olmos VP, Martin MN, et al
     PO-05 - Incidence of venous thromboembolism (VTE) in bile duct tumors (BDT) treated with chemotherapy in ambulatory setting.
     Thromb Res. 2016;140 Suppl 1:S178.
     PubMed     Text format     Abstract available
     
     
     
183. SANTI RM, Ceccarelli M, Catania G, Monagheddu C, et al
     PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
     Thromb Res. 2016;140 Suppl 1:S177.
     PubMed     Text format     Abstract available
     
     
     
184. MARTIN AJ, Ziyatdinov A, Rubio VC, Olmos VP, et al
     PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy.
     Thromb Res. 2016;140 Suppl 1:S177-8.
     PubMed     Text format     Abstract available
     
     
     
185. KONIGSBRUGGE O, Riedl J, Grilz E, Wiltschke C, et al
     PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients.
     Thromb Res. 2016;140 Suppl 1:S176.
     PubMed     Text format     Abstract available
     
     
     
186. PIATEK CI, Tagawa ST, Wei-Tsai D, Hanna D, et al
     OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin.
     Thromb Res. 2016;140 Suppl 1:S174.
     PubMed     Text format     Abstract available
     
     
     
187. COSMI B, Legnani C, Ghirarduzzi A, De Micheli V, et al
     OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism.
     Thromb Res. 2016;140 Suppl 1:S174.
     PubMed     Text format     Abstract available
     
     
     
188. ROSS JA, Miller M, Hernandez CR
     OC-13 - Safe and effective use of direct oral anticoagulants (DOAC) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism.
     Thromb Res. 2016;140 Suppl 1:S173-4.
     PubMed     Text format     Abstract available
     
     
     
189. PETCH S, Norris LA, O'Toole SA, Gleeson N, et al
     OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice.
     Thromb Res. 2016;140 Suppl 1:S173.
     PubMed     Text format     Abstract available
     
     
     
190. YOUNG A, Phillips J, Hancocks H, Hill C, et al
     OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.
     Thromb Res. 2016;140 Suppl 1:S172-3.
     PubMed     Text format     Abstract available
     
     
     
191. ANTIC D, Milic N, Todorovic M, Bila J, et al
     OC-07 - Decoding risk for thromboembolic events in lymphoma patients.
     Thromb Res. 2016;140 Suppl 1:S171.
     PubMed     Text format     Abstract available
     
     
     
192. ALEXANDER M, Wolfe R, Ball D, Manser R, et al
     OC-05 - D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer - interim results from a prospective cohort study.
     Thromb Res. 2016;140 Suppl 1:S170.
     PubMed     Text format     Abstract available
     
     
     
193. NAVI BB, Reiner AS, Kamel H, Iadecola C, et al
     OC-02 - Risk of arterial thromboembolism in patients with breast cancer.
     Thromb Res. 2016;140 Suppl 1:S169.
     PubMed     Text format     Abstract available
     
     
     March 2016
194. PARK MS, Perkins SE, Spears GM, Ashrani AA, et al
     Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.
     Thromb Res. 2016;144:40-45.
     PubMed     Text format     Abstract available
     
     
     
195. MARTINELLI I, Maino A, Abbattista M, Bucciarelli P, et al
     Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.
     Thromb Res. 2016;141:153-157.
     PubMed     Text format     Abstract available
     
     
     
196. ISHOLA T, Kirk SE, Guffey D, Voigt K, et al
     Risk factors and co-morbidities in adolescent thromboembolism are different than those in younger children.
     Thromb Res. 2016;141:178-182.
     PubMed     Text format     Abstract available
     
     
     
197. SAMUELSON BT, Gernsheimer T, Estey E, Garcia DA, et al
     Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
     Thromb Res. 2016;141:104-105.
     PubMed     Text format    
     
     
     
198. RATASVUORI M, Lassila R, Laitinen M
     Venous thromboembolism after surgical treatment of non-spinal skeletal metastases - An underdiagnosed complication.
     Thromb Res. 2016;141:124-128.
     PubMed     Text format     Abstract available
     
     
     
199. PRANDONI P, Noventa F, Lensing AW, Prins MH, et al
     Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism.
     Thromb Res. 2016;141:91-92.
     PubMed     Text format    
     
     
     
200. YU TT, Nelson J, Streiff MB, Lanzkron S, et al
     Risk factors for venous thromboembolism in adults with hemoglobin SC or Sbeta thalassemia genotypes.
     Thromb Res. 2016;141:35-38.
     PubMed     Text format     Abstract available
     
     
     
201. BORGDORFF P, Tangelder GJ
     Arguments favoring low versus high dose aspirin in the prophylaxis of venous thromboembolism.
     Thromb Res. 2016;139:121-4.
     PubMed     Text format    
     
     
     
202. FOLSOM AR, Tang W, George KM, Heckbert SR, et al
     Prospective study of gamma' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
     Thromb Res. 2016;139:44-9.
     PubMed     Text format     Abstract available
     
     
     
203. ASHRANI AA, Gullerud RE, Petterson TM, Marks RS, et al
     Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.
     Thromb Res. 2016;139:29-37.
     PubMed     Text format     Abstract available
     
     
     
204. BOVA C, Bianco A, Mascaro V, Nobile CG, et al
     Extended anticoagulation and mortality in venous thromboembolism. A meta-analysis of six randomized trials.
     Thromb Res. 2016;139:22-8.
     PubMed     Text format     Abstract available
     
     
     
205. PRASAD M, McBane R, Reriani M, Lerman LO, et al
     Coronary endothelial dysfunction is associated with increased risk of venous thromboembolism.
     Thromb Res. 2016;139:17-21.
     PubMed     Text format     Abstract available
     
     
     February 2016
206. LABRADOR J, Gonzalez-Rivero J, Monroy R, Lozano FS, et al
     Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
     Thromb Res. 2016 Feb 18. pii: S0049-3848(16)30043.
     PubMed     Text format     Abstract available
     
     
     
207. ROZJABEK HM, Coleman CI, Weeda ER, Peacock WF, et al
     Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.
     Thromb Res. 2016;141:8-10.
     PubMed     Text format    
     
     
     
208. SNEEBOER MM, Hutten BA, Majoor CJ, Bel EH, et al
     Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism.
     Thromb Res. 2016;140:46-50.
     PubMed     Text format     Abstract available
     
     
     
209. LJUNGQVIST M, Holmstrom M, Kieler H, Odeberg J, et al
     Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.
     Thromb Res. 2016;138:80-5.
     PubMed     Text format     Abstract available
     
     
     
210. JORGENSEN CC, Kehlet H
     Early thromboembolic events </=1week after fast-track total hip and knee arthroplasty.
     Thromb Res. 2016;138:37-42.
     PubMed     Text format     Abstract available
     
     
     
211. OLIVIER CB, Weik P, Meyer M, Weber S, et al
     TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
     Thromb Res. 2016;138:63-8.
     PubMed     Text format     Abstract available
     
     
     December 2015
212. ZHOU X, Wen W, Shan X, Qian J, et al
     MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism.
     Thromb Res. 2015 Dec 10. pii: S0049-3848(15)30219.
     PubMed     Text format     Abstract available
     
     
     
213. WANG CY, Ignjatovic V, Francis P, Cain T, et al
     Risk factors and clinical features of acute pulmonary embolism in children from the community.
     Thromb Res. 2015 Dec 10. pii: S0049-3848(15)30220.
     PubMed     Text format     Abstract available
     
     
     
214. PEIMAN S, Abbasi M, Allameh SF, Asadi Gharabaghi M, et al
     Subsegmental pulmonary embolism: A narrative review.
     Thromb Res. 2015 Dec 8. pii: S0049-3848(15)30218.
     PubMed     Text format     Abstract available
     
     
     
215. SUGIURA K, Kobayashi T, Ojima T
     Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
     Thromb Res. 2015 Dec 2. pii: S0049-3848(15)30216.
     PubMed     Text format     Abstract available
     
     
     November 2015
216. CARPENTER SL, Goldman J, Sherman AK, Jeremiah Bell J, et al
     Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children.
     Thromb Res. 2015 Nov 25. pii: S0049-3848(15)30205.
     PubMed     Text format     Abstract available
     
     
     
217. GROSSE SD, Nelson RE, Nyarko KA, Richardson LC, et al
     The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
     Thromb Res. 2015 Nov 24. pii: S0049-3848(15)30209.
     PubMed     Text format     Abstract available
     
     
     
218. CARRUZZO P, Mean M, Limacher A, Aujesky D, et al
     Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism.
     Thromb Res. 2015 Nov 24. pii: S0049-3848(15)30210.
     PubMed     Text format     Abstract available
     
     
     
219. EDWIN NC, Khoury MN, Sohal D, McCrae KR, et al
     Recurrent venous thromboembolism in glioblastoma.
     Thromb Res. 2015 Nov 22. pii: S0049-3848(15)30203.
     PubMed     Text format     Abstract available
     
     
     
220. HEATH OM, van Beekhuizen HJ, Nama V, Kolomainen D, et al
     Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases.
     Thromb Res. 2015 Nov 22. pii: S0049-3848(15)30206.
     PubMed     Text format     Abstract available
     
     
     
221. QIAN C, Yan H, Hu X, Zhang W, et al
     Increased risk of venous thromboembolism in patients with brain tumors: A systematic review and meta-analysis.
     Thromb Res. 2015 Nov 20. pii: S0049-3848(15)30194.
     PubMed     Text format     Abstract available
     
     
     
222. MASOTTI L, Verdiani V, Cei M, Cioppi A, et al
     The predictive role of the Bova risk score in acute normotensive pulmonary embolism: A retrospective analysis on a real life cohort.
     Thromb Res. 2015 Nov 20. pii: S0049-3848(15)30197.
     PubMed     Text format    
     
     
     
223. BACH AG, Bandzauner R, Nansalmaa B, Schurig N, et al
     Timing of pulmonary embolism diagnosis in the emergency department.
     Thromb Res. 2015 Nov 18. pii: S0049-3848(15)30195.
     PubMed     Text format    
     
     
     
224. ALVARADO-MORENO JA, Hernandez-Lopez R, Chavez-Gonzalez A, Yoder MC, et al
     Endothelial colony-forming cells: Biological and functional abnormalities in patients with recurrent, unprovoked venous thromboembolic disease.
     Thromb Res. 2015 Nov 10. pii: S0049-3848(15)30181.
     PubMed     Text format     Abstract available
     
     
     
225. DELATE T, Hsiao W, Kim B, Witt DM, et al
     Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.
     Thromb Res. 2015 Nov 10. pii: S0049-3848(15)30185.
     PubMed     Text format     Abstract available
     
     
     
226. MWIRIGI A, McDonald V, Shapiro S, Hunt BJ, et al
     Is there benefit in extensive screening for cancer in patients with unprovoked venous thromboembolism?
     Thromb Res. 2015 Nov 6. pii: S0049-3848(15)30174.
     PubMed     Text format    
     
     
     
227. SWANEPOEL AC, Pretorius E
     Prevention and follow-up in thromboembolic ischemic stroke: Do we need to think out of the box?
     Thromb Res. 2015 Nov 4. pii: S0049-3848(15)30177.
     PubMed     Text format     Abstract available
     
     
     October 2015
228. PORTILLO J, de la Rocha IV, Font L, Braester A, et al
     Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
     Thromb Res. 2015 Oct 30. pii: S0049-3848(15)30175.
     PubMed     Text format     Abstract available
     
     
     
229. AL-ANI F, Shariff S, Siqueira L, Seyam A, et al
     Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data.
     Thromb Res. 2015 Oct 29. pii: S0049-3848(15)30167.
     PubMed     Text format     Abstract available
     
     
     
230. PESAVENTO R, Visona A, Villalta S, Vescovo G, et al
     Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism.
     Thromb Res. 2015 Oct 28. pii: S0049-3848(15)30165.
     PubMed     Text format    
     
     
     
231. MANSFIELD AS, Tafur AJ, Vulih D, Smith GL, et al
     Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.
     Thromb Res. 2015 Oct 20. pii: S0049-3848(15)30158.
     PubMed     Text format     Abstract available
     
     
     
232. OKOROH EM, Boulet SL, George MG, Craig Hooper W, et al
     Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome.
     Thromb Res. 2015 Oct 17. pii: S0049-3848(15)30154.
     PubMed     Text format     Abstract available
     
     
     
233. MEYER MR, Witt DM, Delate T, Johnson SG, et al
     Thrombophilia testing patterns amongst patients with acute venous thromboembolism.
     Thromb Res. 2015 Oct 15. pii: S0049-3848(15)30151.
     PubMed     Text format     Abstract available
     
     
     
234. WITT DM, Clark NP, Martinez K, Schroeder A, et al
     Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
     Thromb Res. 2015 Oct 7. pii: S0049-3848(15)30134.
     PubMed     Text format     Abstract available
     
     
     September 2015
235. WASSEL CL, Rasmussen-Torvik LJ, Callas PW, Denenberg JO, et al
     A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort.
     Thromb Res. 2015 Sep 26. pii: S0049-3848(15)30127.
     PubMed     Text format     Abstract available
     
     
     
236. LEE SE, Jeon YW, Yoon JH, Cho BS, et al
     Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients.
     Thromb Res. 2015 Sep 26. pii: S0049-3848(15)30132.
     PubMed     Text format     Abstract available
     
     
     
237. SUGIURA K, Kobayashi T, Ojima T
     Thromboembolism as the adverse event of combined oral contraceptives in Japan.
     Thromb Res. 2015 Sep 16. pii: S0049-3848(15)30122.
     PubMed     Text format     Abstract available
     
     
     
238. GAO GY, Yang P, Liu M, Ding M, et al
     Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis.
     Thromb Res. 2015 Sep 12. pii: S0049-3848(15)30123.
     PubMed     Text format     Abstract available
     
     
     
239. VERSO M, Chiari R, Mosca S, Franco L, et al
     Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma.
     Thromb Res. 2015 Sep 9. pii: S0049-3848(15)30117.
     PubMed     Text format    
     
     
     
240. UNGPRASERT P, Tanratana P, Srivali N
     Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis.
     Thromb Res. 2015 Sep 6. pii: S0049-3848(15)30115.
     PubMed     Text format     Abstract available
     
     
     
241. LUND JL, Ostgard LS, Prandoni P, Sorensen HT, et al
     Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark.
     Thromb Res. 2015 Sep 5. pii: S0049-3848(15)30112.
     PubMed     Text format     Abstract available
     
     
     
242. SZLAUER A, Mielimonka A, Glowacki R, Borowczyk K, et al
     Protein N-linked homocysteine is associated with recurrence of venous thromboembolism.
     Thromb Res. 2015 Sep 5. pii: S0049-3848(15)30113.
     PubMed     Text format     Abstract available
     
     
     
243. KELLER K, Prochaska JH, Coldewey M, Gobel S, et al
     History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.
     Thromb Res. 2015 Sep 3. pii: S0049-3848(15)30107.
     PubMed     Text format     Abstract available
     
     
     
244. SPRONK HM, Cannegieter S, Morange P, Hackeng T, et al
     Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome).
     Thromb Res. 2015;136 Suppl 1:S8-S12.
     PubMed     Text format    
     
     
     
245. VAN DER MEIJDEN PE, Ozaki Y, Ruf W, de Laat B, et al
     Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome).
     Thromb Res. 2015;136 Suppl 1:S3-7.
     PubMed     Text format    
     
     
     
246. TEN CATE-HOEK AJ, Weitz JI, Gailani D, Meijer K, et al
     Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).
     Thromb Res. 2015;136 Suppl 1:S13-8.
     PubMed     Text format    
     
     
     August 2015
247. KLINE JA, Steuerwald NM, Watts JA, Courtney M, et al
     Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.
     Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30097.
     PubMed     Text format     Abstract available
     
     
     
248. FOLSOM AR, Alonso A, George KM, Roetker NS, et al
     Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.
     Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30101.
     PubMed     Text format     Abstract available
     
     
     
249. BIANCONI D, Schuler A, Pausz C, Geroldinger A, et al
     Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients.
     Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30093.
     PubMed     Text format     Abstract available
     
     
     July 2015
250. SINDET-PEDERSEN C, Pallisgaard JL, Olesen JB, Gislason GH, et al
     Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis.
     Thromb Res. 2015 Jul 29. pii: S0049-3848(15)30073.
     PubMed     Text format     Abstract available
     
     
     
251. HAN C, Zhao Y, Cheng W, Yang J, et al
     The performance of age-adjusted D-dimer cut-off in Chinese outpatients with suspected venous thromboembolism.
     Thromb Res. 2015 Jul 26. pii: S0049-3848(15)30075.
     PubMed     Text format     Abstract available
     
     
     
252. BUCCIARELLI P, Maino A, Felicetta I, Abbattista M, et al
     Association between red cell distribution width and risk of venous thromboembolism.
     Thromb Res. 2015 Jul 25. pii: S0049-3848(15)30071.
     PubMed     Text format     Abstract available
     
     
     
253. POSCH F, Konigsbrugge O, Zielinski C, Pabinger I, et al
     Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.
     Thromb Res. 2015 Jul 17. pii: S0049-3848(15)30062.
     PubMed     Text format     Abstract available
     
     
     
254. STARIKOVA I, Jamaly S, Sorrentino A, Blondal T, et al
     Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals.
     Thromb Res. 2015 Jul 15. pii: S0049-3848(15)30057.
     PubMed     Text format     Abstract available
     
     
     
255. ZOLLER B, Palmer K, Li X, Sundquist J, et al
     Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.
     Thromb Res. 2015 Jul 14. pii: S0049-3848(15)30056.
     PubMed     Text format     Abstract available
     
     
     
256. YANG Y, Zhang XZ, Ng HS, Fong JC, et al
     The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
     Thromb Res. 2015 Jul 6. pii: S0049-3848(15)30045.
     PubMed     Text format     Abstract available
     
     
     
257. FAIZ AS, Khan I, Beckman MG, Bockenstedt P, et al
     Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism.
     Thromb Res. 2015 Jul 5. pii: S0049-3848(15)30049.
     PubMed     Text format     Abstract available
     
     
     June 2015
258. HEIT JA, Lahr BD, Ashrani AA, Petterson TM, et al
     Predictors of Venous Thromboembolism Recurrence, Adjusted for Treatments and Interim Exposures: A Population-based Case-cohort Study.
     Thromb Res. 2015 Jun 24. pii: S0049-3848(15)30041.
     PubMed     Text format     Abstract available
     
     
     
259. LINDQVIST PG, von Kanel R
     How to avoid venous thromboembolism in women at increased risk - with special focus on low-risk periods.
     Thromb Res. 2015 Jun 19. pii: S0049-3848(15)30032.
     PubMed     Text format     Abstract available
     
     
     
260. DEN EXTER PL, van der Hulle T, Hartmann IJ, Jimenez D, et al
     Reliability of diagnosing incidental pulmonary embolism in cancer patients.
     Thromb Res. 2015 Jun 19. pii: S0049-3848(15)30039.
     PubMed     Text format     Abstract available
     
     
     
261. MINIATI M
     Perfusion lung scintigraphy for pulmonary embolism.
     Thromb Res. 2015 Jun 4. pii: S0049-3848(15)30014.
     PubMed     Text format    
     
     
     May 2015
262. COHEN A, Jeyaindran S, Kim JY, Park K, et al
     Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants.
     Thromb Res. 2015 May 27. pii: S0049-3848(15)30003.
     PubMed     Text format     Abstract available
     
     
     
263. VAN ES J, Douma RA, Hezemans RE, Penaloza A, et al
     Accuracy of X-ray with perfusion scan in young patients with suspected pulmonary embolism.
     Thromb Res. 2015 May 21. pii: S0049-3848(15)00245.
     PubMed     Text format     Abstract available
     
     
     
264. XIE J, Ma J, Kang P, Zhou Z, et al
     Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases.
     Thromb Res. 2015 May 21. pii: S0049-3848(15)00241.
     PubMed     Text format     Abstract available
     
     
     
265. SIMKOVIC M, Vodarek P, Motyckova M, Belada D, et al
     Venous thromboembolism in patients with chronic lymphocytic leukemia.
     Thromb Res. 2015 May 20. pii: S0049-3848(15)00237.
     PubMed     Text format     Abstract available
     
     
     
266. BAUDOUY D, Moceri P, Chiche O, Bouvier P, et al
     B blood group: A strong risk factor for venous thromboembolism recurrence.
     Thromb Res. 2015 May 8. pii: S0049-3848(15)00227.
     PubMed     Text format     Abstract available
     
     
     
267. ARLIKAR SJ, Atchison CM, Amankwah EK, Ayala IA, et al
     Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.
     Thromb Res. 2015 May 3. pii: S0049-3848(15)00208.
     PubMed     Text format     Abstract available
     
     
     
268. COMEROTA AJ, Oostra C, Fayad Z, Gunning W, et al
     A histological and functional description of the tissue causing chronic postthrombotic venous obstruction.
     Thromb Res. 2015;135:882-7.
     PubMed     Text format     Abstract available
     
     
     
269. KUROIWA M, Takahira N, Ujihashi Y, Miida K, et al
     Reduction in the soles of graduated compression stockings prevents falls without reducing the preventive effect for venous stasis.
     Thromb Res. 2015;135:877-81.
     PubMed     Text format     Abstract available
     
     
     
270. LARSEN AC, Frokjaer JB, Fisker RV, Iyer V, et al
     Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.
     Thromb Res. 2015;135:802-8.
     PubMed     Text format     Abstract available
     
     
     April 2015
271. LIPPI G, Cervellin G, Mattiuzzi C
     Red meat, processed meat and the risk of venous thromboembolism: Friend or foe?
     Thromb Res. 2015 Apr 29. pii: S0049-3848(15)00199.
     PubMed     Text format     Abstract available
     
     
     
272. MARVIG CL, Verhoef TI, de Boer A, Kamali F, et al
     Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants.
     Thromb Res. 2015 Apr 25. pii: S0049-3848(15)00198.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: